Does METHYLPREDNISOLONE Cause Neoplasm malignant? 147 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 147 reports of Neoplasm malignant have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 0.2% of all adverse event reports for METHYLPREDNISOLONE.
147
Reports of Neoplasm malignant with METHYLPREDNISOLONE
0.2%
of all METHYLPREDNISOLONE reports
52
Deaths
37
Hospitalizations
How Dangerous Is Neoplasm malignant From METHYLPREDNISOLONE?
Of the 147 reports, 52 (35.4%) resulted in death, 37 (25.2%) required hospitalization, and 21 (14.3%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 147 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLPREDNISOLONE Cause?
Off label use (10,364)
Drug ineffective (9,959)
Product use in unapproved indication (4,115)
Condition aggravated (3,784)
Headache (3,419)
Fatigue (3,250)
Pyrexia (3,226)
Pain (3,165)
Nausea (3,105)
Pneumonia (3,006)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which METHYLPREDNISOLONE Alternatives Have Lower Neoplasm malignant Risk?
METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE
METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE
METHYLPREDNISOLONE vs METILDIGOXIN
METHYLPREDNISOLONE vs METOCLOPRAMIDE
METHYLPREDNISOLONE vs METOLAZONE